Japan Likely to Take FDA’s Anticipated EUA as Cue for “Special” Remdesivir OK

May 1, 2020
As overseas media reports the FDA’s emergency use authorization (EUA) for remdesivir is imminent following positive COVID-19 data, the Japanese government believes that such nod will constitute legal grounds for giving its “special approval” for the Gilead Science medicine, according...read more